# High-Dose Benzylpenicillin Treatment-Induced Febrile Neutropenia in HIV-Infected Male with Neurosyphilis: Case Report

**Authors:** Inga Sabeckyte-Boveiniene, Kotryna Krupeckaite, Svajune Petkeviciute, Evelina Pukenyte, Aukse Mickiene, Danguole Vaznaisiene

PMC · DOI: 10.3390/antibiotics14060560 · 2025-05-30

## TL;DR

A man with HIV developed severe neutropenia after high-dose benzylpenicillin treatment for neurosyphilis, highlighting the need for early diagnosis and proper management.

## Contribution

Reports a rare case of febrile neutropenia caused by high-dose benzylpenicillin in an HIV-infected patient with neurosyphilis.

## Key findings

- The patient showed severe leukopenia and neutropenia without signs of other infections.
- Treatment with cephalosporin, vancomycin, and G-CSF led to rapid clinical improvement.
- The case emphasizes the importance of considering drug-induced neutropenia in similar patients.

## Abstract

Background: Prevention of an irreversible sequalae in neurosyphilis patients requires immediate high-dose intravenous benzylpenicillin administered for a prolonged period of time. However, life-threatening neutropenia has been reported as one of the complications following extended usage of benzylpenicillin. Case presentation: We report a 54-year-old male patient with HIV who developed high-dose benzylpenicillin-induced febrile neutropenia during neurosyphilis treatment. The patient developed a fever of up to 39.8 °C, severe leukopenia (<1 × 109/L), and neutropenia (0.2 × 109/L). He also presented with slightly elevated C-reactive protein and procalcitonin levels but had no clear symptoms of other infections. The diagnosis was confirmed by excluding other possible causes of neutropenia: flu, measles, sepsis, and HIV-related neutropenia. Third-generation antipseudomonal cephalosporin in combination with vancomycin and granulocyte colony-stimulating factor were administered, and the patient saw a rapid improvement in clinical symptoms and laboratory findings. Conclusions: High-dose benzylpenicillin-induced neutropenia should be considered a complication after prolonged periods of neurosyphilis treatment with high-dose benzylpenicillin when there is no evidence of other potential causes of neutropenia. Early diagnosis and proper treatment are critical in order to prevent this dangerous condition from deteriorating further.

## Linked entities

- **Chemicals:** benzylpenicillin (PubChem CID 5904), cephalosporin (PubChem CID 25058126), vancomycin (PubChem CID 14969)
- **Diseases:** neurosyphilis (MONDO:0004944), leukopenia (MONDO:0003785), flu (MONDO:0005812), measles (MONDO:0004619)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** infections (MESH:D007239), fever (MESH:D005334), flu (MESH:D007251), leukopenia (MESH:D007970), neutropenia (MESH:D009503), Neurosyphilis (MESH:D009494), Febrile Neutropenia (MESH:D064147), sepsis (MESH:D018805), measles (MESH:D008457), HIV (MESH:D015658)
- **Chemicals:** Benzylpenicillin (MESH:D010400), vancomycin (MESH:D014640), cephalosporin (MESH:D002511)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12190045/full.md

---
Source: https://tomesphere.com/paper/PMC12190045